Lista de obras -

A blood-brain barrier (BBB) disrupter is also a potent α-synuclein (α-syn) aggregation inhibitor: a novel dual mechanism of mannitol for the treatment of Parkinson disease (PD)

artículo científico publicado en 2013

A novel, sensitive assay for behavioral defects in Parkinson's disease model Drosophila

artículo científico publicado en 2012

Altered protein glycosylation predicts Alzheimer's disease and modulates its pathology in disease model Drosophila

artículo científico publicado en 2017

Cl-NQTrp Alleviates Tauopathy Symptoms in a Model Organism through the Inhibition of Tau Aggregation-Engendered Toxicity

artículo científico publicado en 2016

Cutting in-line with iron: ribosomal function and non-oxidative RNA cleavage

artículo científico publicado en 2020

Differential effects of putative N-glycosylation sites in human Tau on Alzheimer's disease-related neurodegeneration

artículo científico publicado en 2020

Differential inhibition of α-synuclein oligomeric and fibrillar assembly in parkinson's disease model by cinnamon extract

artículo científico publicado en 2012

Distinct Effects of O-GlcNAcylation and Phosphorylation of a Tau-Derived Amyloid Peptide on Aggregation of the Native Peptide

artículo científico publicado en 2018

Enhanced bioavailability of polyaromatic hydrocarbons in the form of mucin complexes.

artículo científico publicado en 2011

Inhibiting α-synuclein oligomerization by stable cell-penetrating β-synuclein fragments recovers phenotype of Parkinson's disease model flies

artículo científico publicado en 2010

Inhibition of the Aggregation and Toxicity of the Minimal Amyloidogenic Fragment of Tau by Its Pro-Substituted Analogues

artículo científico publicado en 2017

Interplay between protein glycosylation pathways in Alzheimer's disease.

artículo científico publicado en 2017

Mutually stabilizing interactions between proto-peptides and RNA

scientific article published on 19 June 2020

Naphthoquinone-Tryptophan Hybrid Inhibits Aggregation of the Tau-Derived Peptide PHF6 and Reduces Neurotoxicity.

artículo científico publicado en 2016

Novel model of secreted human tau protein reveals the impact of the abnormal N-glycosylation of tau on its aggregation propensity

artículo científico publicado en 2019

Prebiotic Peptides: Molecular Hubs in the Origin of Life

artículo científico publicado en 2020

Root of the Tree: The Significance, Evolution, and Origins of the Ribosome

artículo científico publicado en 2020

Selective Inhibition of Aggregation and Toxicity of a Tau-Derived Peptide using Its Glycosylated Analogues

artículo científico publicado en 2016

Selective incorporation of proteinaceous over nonproteinaceous cationic amino acids in model prebiotic oligomerization reactions

scientific article published on 29 July 2019

The pH dependent mechanisms of non-enzymatic peptide bond cleavage reactions

scientific article published on 01 December 2019

Tryptophan-galactosylamine conjugates inhibit and disaggregate amyloid fibrils of Aβ42 and hIAPP peptides while reducing their toxicity

artículo científico publicado en 2020

Lista de obras de

A blood-brain barrier (BBB) disrupter is also a potent α-synuclein (α-syn) aggregation inhibitor: a novel dual mechanism of mannitol for the treatment of Parkinson disease (PD)

A novel, sensitive assay for behavioral defects in Parkinson's disease model Drosophila

Altered protein glycosylation predicts Alzheimer's disease and modulates its pathology in disease model Drosophila

Cl-NQTrp Alleviates Tauopathy Symptoms in a Model Organism through the Inhibition of Tau Aggregation-Engendered Toxicity

Cutting in-line with iron: ribosomal function and non-oxidative RNA cleavage

Differential effects of putative N-glycosylation sites in human Tau on Alzheimer's disease-related neurodegeneration

Differential inhibition of α-synuclein oligomeric and fibrillar assembly in parkinson's disease model by cinnamon extract

Distinct Effects of O-GlcNAcylation and Phosphorylation of a Tau-Derived Amyloid Peptide on Aggregation of the Native Peptide

Enhanced bioavailability of polyaromatic hydrocarbons in the form of mucin complexes.

Inhibiting α-synuclein oligomerization by stable cell-penetrating β-synuclein fragments recovers phenotype of Parkinson's disease model flies

Inhibition of the Aggregation and Toxicity of the Minimal Amyloidogenic Fragment of Tau by Its Pro-Substituted Analogues

Interplay between protein glycosylation pathways in Alzheimer's disease.

Mutually stabilizing interactions between proto-peptides and RNA

Naphthoquinone-Tryptophan Hybrid Inhibits Aggregation of the Tau-Derived Peptide PHF6 and Reduces Neurotoxicity.

Novel model of secreted human tau protein reveals the impact of the abnormal N-glycosylation of tau on its aggregation propensity

Prebiotic Peptides: Molecular Hubs in the Origin of Life

Root of the Tree: The Significance, Evolution, and Origins of the Ribosome

Selective Inhibition of Aggregation and Toxicity of a Tau-Derived Peptide using Its Glycosylated Analogues

Selective incorporation of proteinaceous over nonproteinaceous cationic amino acids in model prebiotic oligomerization reactions

The pH dependent mechanisms of non-enzymatic peptide bond cleavage reactions

Tryptophan-galactosylamine conjugates inhibit and disaggregate amyloid fibrils of Aβ42 and hIAPP peptides while reducing their toxicity